While the pharmaceutical industry is relatively concentrated already, consolidation will continue in the future as companies struggle with high R&D costs and uncertain pipeline success rates. Drawing on its extensive experience guiding clients through uncertainty, and mergers and acquisitions, CAP partners with clients to ensure that executive compensation supports a successful close and integration process. CAP helps its pharmaceutical clients improve their ability to attract, retain, and motivate key executive talent in order to achieve their growth strategies. Learn more about CAP’s expertise in the pharmaceutical industry here or contact us for additional information.

Upcoming Events See All

Jun 03, 2020

Equilar: Executive Compensation Summit

San Diego, CA

Partner Dan Laddin plans to lead a discussion about the ongoing quarrel between the Securities and Exchange Commission (SEC) and Institutional Shareholder Services (ISS)…
  • Christopher Earnest
  • Daniel Laddin

Jun 07, 2020

WorldatWork: Total Rewards Conference & Exhibition

Minneapolis, MN

Partner Eric Hosken has been invited to provide his expertise on both the challenges of managing the recruitment and exiting top executives as well…
  • Eric Hosken

Jun 25, 2020

Equilar & Compensation Advisory Partners: Energy Industry Virtual Roundtable

Webinar

Partner Chris Earnest will discuss trends and best practices for senior compensation professionals in the Energy industry to deal with the global pandemic.  …
  • Christopher Earnest